Evidence suggested that serum albumin can combine with amyloid-β and can reduce its neurotoxicity by inhibiting its aggregation and fibrosis, thus preventing further progression of cognitive decline (Stanyon and Viles, 2012). The gene discussed is ALB; the disease is Mental deterioration.